IAN
GILD icon

Integrated Advisors Network’s Gilead Sciences GILD Stock Holding History

Integrated Advisors Network’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$301K Sell
2,160
-5,666
-72% -$793K 0.02% 557
2025
Q4 		$961K Sell
7,826
-1,013
-11% -$123K 0.04% 353
2025
Q3 		$981K Buy
8,839
+489
+6% +$55.6K 0.04% 367
2025
Q2 		$926K Buy
8,350
+212
+3% +$22.6K 0.04% 374
2025
Q1 		$912K Buy
8,138
+574
+8% +$59.2K 0.05% 334
2024
Q4 		$699K Sell
7,564
-247
-3% -$22.2K 0.03% 374
2024
Q3 		$655K Sell
7,811
-377
-5% -$28.8K 0.03% 405
2024
Q2 		$562K Sell
8,188
-1,059
-11% -$70.7K 0.03% 411
2024
Q1 		$677K Sell
9,247
-753
-8% -$57.9K 0.03% 388
2023
Q4 		$810K Sell
10,000
-4,543
-31% -$354K 0.05% 322
2023
Q3 		$1.09M Buy
14,543
+238
+2% +$18.3K 0.07% 262
2023
Q2 		$1.1M Sell
14,305
-1,534
-10% -$122K 0.06% 269
2023
Q1 		$1.31M Buy
15,839
+540
+4% +$44.7K 0.08% 241
2022
Q4 		$1.31M Sell
15,299
-1,261
-8% -$99.9K 0.08% 243
2022
Q3 		$1.02M Sell
16,560
-1,194
-7% -$75.3K 0.07% 266
2022
Q2 		$1.1M Buy
17,754
+2,275
+15% +$141K 0.07% 261
2022
Q1 		$920K Buy
15,479
+1,802
+13% +$115K 0.05% 325
2021
Q4 		$993K Buy
13,677
+1,975
+17% +$136K 0.06% 286
2021
Q3 		$817K Buy
11,702
+1,028
+10% +$72.2K 0.05% 307
2021
Q2 		$735K Buy
10,674
+219
+2% +$14.6K 0.05% 287
2021
Q1 		$676K Buy
10,455
+1,236
+13% +$79.7K 0.06% 271
2020
Q4 		$537K Buy
9,219
+690
+8% +$41.6K 0.06% 275
2020
Q3 		$539K Sell
8,529
-1,938
-19% -$134K 0.07% 240
2020
Q2 		$805K Sell
10,467
-1,852
-15% -$142K 0.09% 203
2020
Q1 		$921K Buy
12,319
+5,359
+77% +$370K 0.18% 142
2019
Q4 		$452K Buy
+6,960
New +$453K 0.06% 262

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Integrated Advisors Network's GILD Position: Q1 2026 in Review

Integrated Advisors Network reduced its Gilead Sciences (GILD) stake by 72% in Q1 2026, selling an estimated $793K and leaving 2,160 shares worth $301K. The position accounts for 0.02% of the portfolio, ranked #557.

Integrated Advisors Network first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.31M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Integrated Advisors Network held 2,160 shares of Gilead Sciences worth $301K as of Q1 2026.
  • Integrated Advisors Network sold 5,666 Gilead Sciences shares in Q1 2026, an estimated $793K.
  • Gilead Sciences made up 0.02% of Integrated Advisors Network's portfolio in Q1 2026, its #557 holding.
  • Integrated Advisors Network first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • Integrated Advisors Network's Gilead Sciences position peaked at $1.31M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.